Odense University Hospital

51 trials 30 recruiting Academic / non-commercial

Filter these 51 trials by condition, phase, country and more.

Open in Search →

51 Registered trials

30 Recruiting

11 Completed trials

12 Countries active

81 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 12 Phase II/III: 2 Phase II: 20 Phase III/IV: 2 Phase IV: 13 Phase I (Other): 1 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

11 of 11 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Cardiac arrest 2 Chronic kidney disease 2 Type 2 diabetes mellitus 1 Osteopenia 1 Proteinuria 1 Congenital nephrogenic diabetes insipidus 1 Colorectal cancer 1 Pancreatitis chronic 1 Osteoporosis 1

Top IMPs

DAPAGLIFLOZIN 3 HUMAN SERUM ALBUMIN 2 SODIUM CHLORIDE 2 ACETYLSALICYLIC ACID 1 ADRC 1 ADRC001 1 AMILORIDE HYDROCHLORIDE DIHYDRATE 1 ATENOLOL 1 CARVEDILOL 1 CEFUROXIME 1 ELRANATAMAB 1 EMPAGLIFLOZIN 1

All trials — page 3

51 total

FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITO… Ended

2023-506550-20-00 Phase II/III 1 country
Senolytics to Improve Osteoporosis therapy: A randomised controlled clinical trial The SENIOR Trial Ended

2022-502076-23-00 Phase II 1 country
REPLACE - A multi-centre, randomised, double-blinded, placebo controlled 16-weeks study to compare the effect of hydrocortisone and placebo … Ended

2024-513822-53-00 Phase IV 1 country HYDROCORTISONE

Showing 49–51 of 51 trials

← All sponsors A–Z